Urinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity in Patients with Chronic Renal Disease

Urinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity in Patients with Chronic Renal Disease - Urinary Angiotensinogen in Chronic Renal Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-C000000192

Enrollment

Registered

2005-09-13

Start date

2003-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic kidney disease

Exclusion criteria

Exclusion criteria: Patients treated with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers

Design outcomes

Primary

Measure	Time frame
Relationship between urinary angiotensinogen and deterioration of renal function.	—

Secondary

Measure	Time frame
Effects of administration of angiotensin receptor blocker on circulating and urinary angiotensinogen levels.	—

Countries

Japan

Contacts

Public ContactTatsuo Yamamoto

Hamamatsu University School of Medicine First Department of Medicine

ytatsuo@hama-med.ac.jp053-435-2261

Outcome results